Stiripentol: A Novel Antiseizure Medication for the Management of Dravet Syndrome

Stiripentol for the treatment of super-refractory status epilepticus with cross-sensitivity

(2018) Y. Uchida et al.   ACTA NEUROLOGICA SCANDINAVICA

Extending the use of stiripentol to SLC13A5 -related epileptic encephalopathy

(2018) Afnan Alhakeem et al.   BRAIN & DEVELOPMENT

Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study

(2018) Kenneth A Myers et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Efficacy of Stiripentol in Dravet Syndrome with or without SCN1A Mutations

(2018) Min Jung Cho et al.   Journal of Clinical Neurology

Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis

(2018) Jesse Elliott et al.   PHARMACOECONOMICS

Current Treatment Strategies and Future Treatment Options for Dravet Syndrome

(2018) Julie Ziobro et al.   Current Treatment Options in Neurology

A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a 
regimen of stiripentol, clobazam, and valproate in healthy subjects

(2018) Brooks Boyd et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Efficacy of Stiripentol and the Clinical Outcome in Dravet Syndrome

(2018) Edibe Pembegul Yıldız et al.   JOURNAL OF CHILD NEUROLOGY

Clinical and molecular analysis of epilepsy-related genes in patients with Dravet syndrome

(2018) TieJia Jiang et al.   MEDICINE

Add-on stiripentol elevates serum valproate levels in patients with or without concomitant topiramate therapy

(2017) Toshihiro Jogamoto et al.   EPILEPSY RESEARCH

Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel

(2017) Elaine C. Wirrell et al.   PEDIATRIC NEUROLOGY

From genotype to phenotype in Dravet disease

(2017) Svetlana Gataullina et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Audit of use of stiripentol in adults with Dravet syndrome

(2016) S. Balestrini et al.   ACTA NEUROLOGICA SCANDINAVICA

Patients with dravet syndrome in the era of stiripentol: A French cohort cross-sectional study

(2016) Paola De Liso et al.   EPILEPSY RESEARCH

Stiripentol for the treatment of super-refractory status epilepticus

(2015) A. Strzelczyk et al.   ACTA NEUROLOGICA SCANDINAVICA

The European patient with Dravet syndrome: Results from a parent-reported survey on antiepileptic drug use in the European population with Dravet syndrome

(2015) Luis Miguel Aras et al.   EPILEPSY & BEHAVIOR

Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan

(2015) Yushi Inoue et al.   EPILEPSY RESEARCH

Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: Additional supportive evidence

(2014) Yushi Inoue et al.   EPILEPSY RESEARCH

Reassessment of stiripentol pharmacokinetics in healthy adult volunteers

(2014) Sophie Peigné et al.   EPILEPSY RESEARCH

Stiripentol in refractory status epilepticus

(2013) Denise K. Grosenbaugh et al.   EPILEPSIA

Stiripentol in Dravet syndrome: Results of a retrospective U.S. study

(2013) Elaine C. Wirrell et al.   EPILEPSIA

Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome

(2011) Masako Sakauchi et al.   EPILEPSIA

Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study

(2011) Rima Nabbout et al.   EPILEPSIA

Stiripentol open study in Japanese patients with Dravet syndrome

(2009) Yushi Inoue et al.   EPILEPSIA

The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator

(2008) Janet L. Fisher   NEUROPHARMACOLOGY